Madeline King, PharmD, BCIDP is an infectious diseases PGY2 residency program director, and outpatient infectious diseases clinical pharmacist, Cooper University Hospital.
Should Linezolid Replace Clindamycin for Necrotizing Soft Tissue Infections?
October 27th 2023A comparative study found that using linezolid in place of clindamycin in combination with vancomycin for the treatment of necrotizing soft tissue infections resulted in similar 30-day mortality rates but lower rates of acute kidney injury and composite adverse outcomes, suggesting the effectiveness and safety of linezolid as an alternative therapy.
Read More
Influenza Vaccination With SARS-CoV-2 mRNA Booster Shots
November 23rd 2022Drs Jacinda Abdul-Mutakabbir, Madeline King, Rodney Rohde, and expert nurse practitioner Wendy Wright provide insight on receiving the influenza vaccine concurrently with the SARS-CoV-2 booster shot, and comment on data on immune responses from the Moderna and Pfizer/BioNTech vaccines.
Read More
Defining SARS-CoV-2 Bivalent Vaccines and Optimizing Protection Through Vaccination
November 16th 2022Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; Jacinda Abdul-Mutakabbir, PharmD; and Rodney E. Rohde, PhD, MS, SM(ASCP)CM, SVCM, MBCM, FACSc; review what encompasses a bivalent vaccine and give their perspective on how to communicate the role of the vaccine in optimizing protection for patients.
Read More
Evolution of SARS-CoV-2 Variants on Booster Shot Development and Formulations
November 11th 2022Rodney E. Rohde, PhD, MS, SM(ASCP)CM, SVCM, MBCM, FACSc, leads a discussion on the constant evolution of SARS-CoV-2 variants and the impact on vaccine and booster shot development and administration.
Read More
COVID-19 Booster Vaccination Protection Rates
November 11th 2022Jacinda Abdul-Mutakabbir, PharmD; Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; and Madeline King, PharmD, BCIDP, examine the efficacy and real-world implications of the COVID-19 booster shot in terms of vaccination protection rates.
Read More